UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4098.75

Change

+15.25 (+0.37)%

Market Cap

N/A

Volume

556.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-0.50 (-0.22%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.02 (+0.01%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.16 (-0.87%)

USD 588.35B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.08 (-0.54%)

USD 588.35B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.05 (+1.52%)

USD 266.08B
0QZO:LSE 0QZO

+2.10 (+1.92%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.26 (-0.85%)

USD 244.75B
0QZ3:LSE Qualcomm Inc.

+0.88 (+0.51%)

USD 202.26B
0R24:LSE Intel Corp.

-0.03 (-0.12%)

USD 196.14B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.54% 88% B+ 82% B
Dividend Return 0.01% 19% F 19% F
Total Return 11.55% 88% B+ 82% B
Trailing 12 Months  
Capital Gain 15.16% 63% D 64% D
Dividend Return 0.05% 29% F 27% F
Total Return 15.20% 62% D 63% D
Trailing 5 Years  
Capital Gain 30.79% 53% F 64% D
Dividend Return 0.19% 33% F 45% F
Total Return 30.98% 50% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 8.43% 56% F 61% D-
Dividend Return 8.43% 55% F 61% D-
Total Return 0.00% 18% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 12.21% 59% D- 75% C
Risk Adjusted Return 69.05% 68% D+ 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.